Recombinant MAO Enzyme Characterization

Recombinant human MAO-A
and MAO-B, benzylamine, kynuramine, lazabemide, pargyline, clorgyline,
and toloxatone were purchased from Sigma-Aldrich (St. Louis, MO).
Sodium phosphate (dibasic and monobasic anhydrous) was purchased from
Daejung (Siheung, Korea). Dialyzer (6–8 kDa, DiaEasy) was purchased
from BioVision (St. Grove, MA).^{30 (link)}

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Jayan J., Lee J., Kumar S., Manoharan A., Narayanan A.P., Jauhari R., Abdelgawad M.A., Ghoneim M.M., Ebrahim H.A., Mary Zachariah S., Kim H, & Mathew B. (2023). Development of a New Class of Monoamine Oxidase-B Inhibitors by Fine-Tuning the Halogens on the Acylhydrazones. ACS Omega, 8(50), 47606-47615.

Publication 2023

Recombinant human MAO-Aand MAO-B benzylamine kynuramine lazabemide pargyline clorgyline toloxatone

Corresponding Organization : Sunchon National University

Other organizations : Graphic Era University, Al Jouf University, Beni-Suef University, Alfaisal University, Al-Azhar University, Princess Nourah bint Abdulrahman University

Top 5 similar protocols

Variable analysis

independent variables

Recombinant human MAO-A
Recombinant human MAO-B
Benzylamine
Kynuramine
Lazabemide
Pargyline
Clorgyline
Toloxatone

dependent variables

Measured outcomes

control variables

Sodium phosphate (dibasic and monobasic anhydrous)
Dialyzer (6–8 kDa, DiaEasy)

controls

No positive or negative controls were explicitly mentioned.

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!